BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2025 7:53:52 AM | Browse: 74 | Download: 223
 |
Received |
|
2025-06-13 06:28 |
|
Peer-Review Started |
|
2025-06-13 06:29 |
|
First Decision by Editorial Office Director |
|
2025-06-26 08:07 |
|
Return for Revision |
|
2025-06-26 08:07 |
|
Revised |
|
2025-07-08 03:02 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-02 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-02 06:46 |
|
Articles in Press |
|
2025-09-02 06:46 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-31 13:05 |
|
Publish the Manuscript Online |
|
2025-11-27 07:53 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ali Madian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ali Madian, Associate Professor, Consultant, MD, PhD, Department of Internal Medicine, Faculty of Medicine, Al-Azhar University-Assiut, Al Walideyah Al Bahreyah, Assiut 71524, Egypt. a.madian@azhar.edu.eg |
| Key Words |
Nonalcoholic fatty liver disease; Metabolic dysfunction-associated steatotic liver disease; Essential phospholipids; Liver enzymes; Noninvasive diagnostics; Ultrasonography |
| Core Tip |
The MANPOWER study demonstrated that Essentiale Forte N® reduces liver enzyme levels (alanine aminotransferase: 20-37 U/L, aspartate aminotransferase: 17-29 U/L, gamma-glutamyl transferase: 17-24 U/L, P < 0.001) and improves ultrasonography findings in patients with nonalcoholic fatty liver disease, with greater efficacy in severe cases. A liver enzyme-based algorithm offers 72.3% accuracy for noninvasive staging, prompting clinicians to adopt essential phospholipids and researchers to refine scalable diagnostics to address nonalcoholic fatty liver disease’s global burden. |
| Publish Date |
2025-11-27 07:53 |
| Citation |
Madian A. Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action. World J Hepatol 2025; 17(11): 110725 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i11/110725.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i11.110725 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
